Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia

Type of Cancer
Leukemia, Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.